Familial hypercholesterolemia (FH) has a frequency of 0.2% in most populations of the world. In selected populations such as the Afrikaners in South Africa, the Christian Lebanese, and the French Canadians, the disease is more frequent due to the founder effect. Previous studies demonstrated that a single mutation at the LDL receptor locus, the so-called French Canadian deletion, makes up 60% of the mutant genes responsible for FH in the French Canadian population. In this study, efforts were directed to determine if there were other common LDL receptor mutations in this population. Three missense mutations were identified and each mutation was reproduced and expressed in vitro. Two of the three mutations result in the production of an LDL receptor protein that is not processed to its mature form at a normal rate. Molecular assays were developed to detect the mutations directly, and the LDL receptor genes of 130 French Canadian FH heterozygotes were screened for the presence of the three missense mutations as well as two deletions. LDL receptor mutations were detected in 76% of individuals and 14% had one of the three missense mutations. (J. Clin. Invest. 1990Invest. . 85:1014Invest. -1023.) familial hypercholesterolemia-LDL receptors hypercholesterolemia
Introduction
Familial hypercholesterolemia (FH)' is an autosomal dominant disorder due to mutations in the LDL receptor gene (1). FH heterozygotes have a two-to threefold elevation in plasma LDL associated with tendon xanthomas and accelerated atherosclerosis. FH homozygotes have a markedly elevated level of plasma LDL and these individuals often develop coronary atherosclerosis in childhood (1). The LDL receptor gene has been cloned (2) and numerous mutant alleles from individuals with FH have been characterized at a molecular level. A vast 1. Abbreviations used in this paper: EGF, epidermal growth factor; ER, endoplasmic reticulum; FH, familial hypercholesterolemia; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.
array of different mutations in the LDL receptor gene have been described, including nonsense mutations, missense mutations, deletions, and insertions (3) . The mutations have been classified into four groups based on the characteristics of the LDL receptor protein produced (4) . In normal fibroblasts, an LDL receptor precursor protein is produced in the endoplasmic reticulum (ER) and has an apparent molecular mass of 120 kD on SDS gel electrophoresis. Within 30 min the protein is transported to the Golgi complex and increases in size by 40 kD due to the addition of N-and 0-linked sugars. From the Golgi complex, the receptor is transported to the cell surface where it binds its ligand, LDL, and is internalized by endocytosis (5) . LDL receptor alleles with a so-called class 1 mutation fail to produce any LDL receptor protein as determined by immunoprecipitation with an anti-LDL receptor monoclonal antibody (6) . LDL receptor mutations of the class 2 phenotype make a precursor protein that is not transported at a normal rate from the ER to the Golgi complex, and the 120-kD precursor protein accumulates in the ER. Class 3 mutations produce an LDL receptor protein that is transported normally to the cell surface, but fails to bind LDL. And finally, mutations of the class 4 type make an LDL receptor protein that binds LDL normally but fails to be internalized.
The frequency of FH differs quite dramatically in different populations of the world. In the European and North American populations, the frequency of heterozygous FH is estimated to be 0.2% (1). However, in selected other populations such as the Afrikaners of South Africa (7) , the Christian Lebanese (8) , and the French Canadians (9) , the frequency of FH has been found to be two-to fivefold higher. In these populations, one or two mutant alleles at the LDL receptor locus predominate, unlike most populations where almost every unrelated individual with FH has a different LDL receptor mutation (Hobbs H. H., et al., unpublished observations). For example, in the Afrikaners the frequency of FH has been estimated to be five times higher than the general European population, and two LDL receptor missense mutations comprise > 95% of the mutant alleles in 12 Afrikaner FH homozygotes (10) .
In the French Canadian population, the frequency of FH has been estimated to be -0.5%, or about two to three times the rate in the general population (9) . A large deletion (> 10 kb) in the 5' region of the LDL receptor gene (which will be referred to as the French Canadian deletion) has been shown to comprise 60% of mutant LDL receptor alleles causing FH in French Canadians from the Montreal area (11) . It was previously speculated that the high frequency of this deletion in the French Canadian population was due to the founder effect (1 1).
The present-day French Canadian population is descended from -6,000-7,000 original settlers who emigrated from northeastern and western France to eastern Canada in the 17th and 18th centuries ( 12) . The French Canadians remained ge-netically isolated from the English due to social and geographic factors. They were mostly farmers and settled in more remote areas as their numbers grew. The families were large and the French Canadian population expanded rapidly after 1700. Presumably, among the initial group of immigrants there were individuals or families who had FH due to the French Canadian deletion. When the ancestries of some individuals with the French Canadian deletion were traced (including one from San Francisco and another from Massachusetts), all had ancestors from the same small town northeast of Montreal called Kamouraska. This observation supports the hypothesis that these families share ascendants (13) .
Since a single mutation in the LDL receptor gene, i.e., the French Canadian deletion, was found to make up 60% of the mutant alleles in this population, the question arose whether there were other common mutant LDL receptor alleles in the remaining 40%. In another study, Ma et Montreal, Canada. Every FH heterozygote had an elevated LDL level, tendon xanthomas, and a family history of hypercholesterolemia. Their pedigrees were constructed and none were found to be related at the second degree level. Genomic blotting was performed to assay for the presence of the French Canadian deletion and the 5-kb deletion (data not shown) (1 1, 14). Of the 130 FH heterozygotes tested, 77 (59%) were found to have the French Canadian deletion and four (3%) had the '5-kb deletion.
To determine and identify the LDL receptor mutations responsible for FH in the other 38% of these French Canadian heterozygotes, LDL receptor haplotype analysis was performed using genomic DNA extracted from fibroblasts of 11 French Canadian FH homozygotes that had been cultured from skin biopsy specimens by Dr. M. S. Brown and Dr. J. L. Goldstein. The 11 French Canadian FH homozygotes are listed in Table I . The city of origin of the physicians who sent the skin biopsy specimens are given, as well as any history of consanguinity. LDL receptor protein biosynthetic studies had been previously performed using these cultured fibroblasts in the laboratory of Dr. M. S. Brown and Dr. J. L. Goldstein. The cells were radiolabeled with [35S]methionine for 2 h and then washed for 2 h with cold methionine before immunoprecipitation using an anti-receptor MAb, IgG-C7. A quantification of the amount of LDL receptor protein in the precursor (120 kD) and mature form (160 kD) was determined by densitometry, and the results are summarized in Table I . In normal fibroblasts, 100% of the receptor protein is in the 160-kD mature form after a 2-h pulse and 2-h chase. The fibroblasts from FH homozygotes 49, 549, 808, 859, and 896 produced no immunoprecipitable protein and thus were of the class 1 phenotype. FH homozygotes 47, 787, and 896 produced an LDL receptor precursor protein of normal size that failed to be completely converted to the mature 160-kD form after a 2-h chase. FH 883, 807, and 764 produced a protein of normal size that was defective in cell surface binding to either LDL or IgG-C7 (data not shown). Also included in Table I are the results of RNA blot analysis and LDL receptor haplotype analysis which were performed as previously described (15, 24) . Of the 11 FH homozygotes, 8 were found to be homozygous for the same haplotype, and subsequently were determined to be homozygous for the same mutation (Nos. 1-8, Table I ). Three of the FE homozygotes were heterozygous for at least one restriction site and thus were probably compound heterozygotes (Nos. 9-1 1, Table I ). One FH homozygote, FH 764, was half French Canadian; his mother was German and his father was French Canadian, and therefore only his paternal allele was included in the analysis.
Only three different LDL receptor haplotypes were found among the 21 mutant LDL receptor alleles represented in this sample: haplotype 3', haplotype 2, and haplotype 31 (Table I , part B). The fact that only three haplotypes were identified suggested that there may be only three LDL receptor mutations in the sample of 21 mutant LDL receptor alleles screened. The DNA samples were assayed for the presence of the French Canadian deletion by genomic blotting, and it was determined that all the LDL receptor alleles of haplotype 3' (57%) had the French Canadian deletion. None of the FH homozygotes had the 5-kb deletion described by Ma et al. ( 14) . The rest of the mutant LDL alleles had either haplotype 2 (24%) or haplotype 31 (19%). FH 47 and FH 883 were each homozygous for one of the two common haplotypes (haplotypes 2 and 31, respectively), and the coding regions of their LDL receptor genes were sequenced.
Oligonucleotides homologous to intron sequences flanking each of exons 1-17 and the 5' region of exon 18 of the LDL receptor gene (Table II) were used to amplify the coding region ofthe gene by PCR from genomic DNA ofFH 47 and FH 883. For each exon, the amplified DNA fragment containing the exon sequence was purified and subsequently sequenced by the technique of Maxam and Gilbert (19) . One basepair substitution was identified in each FH homozygote when the sequence was compared with the LDL receptor cDNA sequence (25) (Fig. 1 ). In Fig. 1 A, the sequence of the coding strand of exon 3 from a normal individual is compared with FH 883. A single basepair change (a thymidine to guanine substitution) was identified in codon 66, and this substitution would predict an amino acid change of tryptophan to glycine. Fig. 1 (Fig. 1 C) .
To confirm that these three amino acid substitutions were not polymorphisms, each mutation was reproduced in a expression plasmid containing the normal LDL receptor cDNA under the control of the simian virus (SV) 40 promoter and expressed transiently in transfected COS-M6 cells. 48 h after transfection, biosynthetic studies of the LDL receptor protein were performed (Fig. 2) . The cells were pulsed with [35S]methionine for 15 min before chasing with cold methionine for 15, 30, 45, 60, and 120 min. The cell extracts were subjected to immunoprecipitation using IgG-C7 and the products were size-fractionated on a polyacrylamide-SDS gel before performing autoradiography. The results of three separate experiments are shown (Fig. 2) . In each experiment the LDL receptor protein produced by cells transfected with the mutant cDNA was compared with cells transfected with the normal LDL receptor cDNA. Since similar results were obtained in the three experiments using the plasmid expressing the normal LDL receptor cDNA, only one example is given (Fig. 2 A) . Using normal fibroblasts, after a 15-min pulse and no chase only the 1 20-kD precursor protein was seen. By 60 min almost half of the LDL receptor protein was in the mature 160-kD form. It was previously shown by Esser et al. that when the LDL receptor is expressed in COS cells, the processing of the protein from the 120-to the 160-kD mature form is slower than in fibroblasts (23, 26) . Similar results were observed in the current studies. After a 15-min pulse, at least 1 h of chase was required before 50% of the receptor was in its mature 160-kD form. Fig. 2 B shows the results of COS cells transfected with p47 (Cys6' --Tyr). Even after a 120-min chase the LDL receptor precursor protein failed to be converted to the mature form, which is identical to what was observed in the biosynthetic studies performed using fibroblasts from FH 47 (Table  I) . Fig. 2 C shows the results of the same study using cells transfected with a plasmid containing the LDL receptor cDNA with the mutation identical to that found in FH 787 (G8U207-* Lys). These cells produced a protein that was processed more slowly than normal, but unlike FH 47, some of the receptor protein did get processed to the mature 160-kD form. This is consistent with biosynthetic studies of fibroblasts from the FH homozygote 787 (Table I) . Finally, Fig. 2 French Canadian FH heterozygotes that were analyzed, and four out of the six were found to be heterozygous for this mutation. Fig. 3 B shows a similar analysis of exon 14-specific DNA amplified from the same FH homozygotes and six different FH heterozygotes. The duplicate filters were hybridized with end-labeled oligonucleotides homologous to the normal or the mutant sequence. Again, only the normal oligonucleotide hybridized to the normal DNA and the DNA from the other two true homozygotes, FH 883 and 787, but it did not hybridize to the amplified DNA from FH 47. Oligo 47 hybridized with the DNA from FH 47 and both the normal and mutant oligo hybridized with FH 893. Therefore, FH 893 is heterozygous for this mutation. Finally, Fig. 3 C shows the same analysis using amplified DNA samples from exon 4 French Canadian deletion. The second most frequent mutamozygotes there was a similar frequency of the French Canation was the mutation found in FH 883, and this comprised dian deletion (57%), and none of the FH homozygotes had the 7% of the mutant LDL receptor alleles assayed. The next most 5-kb deletion. There was a higher frequency of the three miscommon mutation was the mutation identified in FH 47, and sense mutations, but each had the same relative frequency as this mutation was found in 5% of the sample. Finally, the two in the FH heterozygotes. least common mutations were the 5-kb deletion (14) , and the exon 4 mutation identified in FH 787; they had allelic freDiscussion quencies of 3 and 2%, respectively. (27) . 10 RFLPs associated with the LDL receptor gene were used to determine the LDL receptor haplotypes in the FH homozygotes (15) . Only three LDL receptor haplotypes were identified in the 21 mutant LDL receptor alleles surveyed. Three ofthe FH homozygotes who did not have the French Canadian deletion were homozygous at every site. Homozygosity for all 10 restriction sites suggested homozygosity for a mutation since the heterozygosity index using the 10 RFLPs was previously shown to be 85% (15 have not yet been seen in any individuals outside of Quebec. However, the basepair substitution identified in FH 787 has been found in another FH homozygote, FH 525. The RFLP haplotype linked to a mutation can be used to estimate the number of times the mutation has occurred, as has been done at the (l-globin locus for sickle cell anemia and a subset of mutations causing #-thalassemia (36-38). If the same mutation is found in unrelated individuals on an allele of an identical RFLP haplotype, it is likely that they share an ascendent. If, however, the mutation is found on a very different haplotype, then it is probable that the mutation has occurred more than once, assuming that it was not an ancient event. FH 525 is from Mexico and though he is homozygous for the same mutation as FH 787 the mutation is found on an LDL receptor allele of a completely different haplotype. FH 525 is homozygous for haplotype 31 and FH 787 is homozygous for haplotype 2; these two haplotypes differ at four sites (see Table I , part B). The fact that the same mutation is present on LDL receptor alleles of different haplotypes suggests that the mutation occurred more than once. The mutation consists of a base-substitution of a thymidine for a cytosine at a CpG dimer, and CpG dimers have been shown to be hot spots for mutational events in the human genome (39, 40) .
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The high frequency of FH in the French Canadian population is presumed to be due to the founder effect. This is supported by the fact that when families with the French Canadian deletion were traced back to the original immigrants, they were all found to originate from the same region (13). The mutations described in this paper are less frequent then the French Canadian deletion, and this may represent later entry of the mutations into the population. The frequency of the mutations may vary significantly in other regions of Quebec province due to differences in the migration patterns of the early settlers. A demographic study of each mutation would facilitate the analysis of LDL receptor gene mutations in the French Canadians.
By performing Southern blot analysis to detect the two deletions, and dot blot oligonucleotide hybridization studies to detect the three missense mutations, 76% of the mutant alleles responsible for FH in the Montreal region can be detected directly. The percentages for each of the mutations may be quite different in other regions of Eastern Canada. The ability to detect mutations at the LDL receptor locus directly in a majority of individuals with FH will facilitate the prenatal diagnosis of homozygous FH in the French Canadian population. The assays can also be used to confirm the diagnosis of FH in a patient where the clinical diagnosis is not clear. Whether or not any ofthese mutations are a common cause of FH in France has not been investigated.
